Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i wt » _ wt (Expand Search), i w (Expand Search), i et (Expand Search)
-
61
Simultaneous ablation of Syt1 and Syt7 decreases the RRP size at excitatory synapses.
Published 2015“…<p><b>A & B.</b> Ablation of both Syt1 and Syt7 in hippocampal neurons decreases the RRP size at excitatory synapses in a manner that is rescued by WT Syt7 (Syt7<sup>WT</sup>) or Syt1 (Syt1<sup>WT</sup>) but not by mutant Syt7 (Syt7<sup>C2A</sup>*<sup>B</sup>*) or Syt1 (Syt1<sup>C2A</sup>*<sup>B</sup>*) with altered top-loop sequences containing the Ca<sup>2+</sup>-binding sequences (A, Syt7 rescue; B, Syt1 rescue). …”
-
62
-
63
-
64
-
65
-
66
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
67
-
68
-
69
-
70
-
71
-
72
IgG-mediated systemic anaphylaxis decreased in BasoDTR mice.
Published 2013“…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
-
73
Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation.
Published 2010“…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”
-
74
-
75
-
76
-
77
SLE decreases risk for hormonal cancers.
Published 2021“…An OR to the left of the solid line represents a reduction in risk. (a) Breast cancer incidence in female SLE cohort is significantly decreased by SLE status (OR 0.52, 95% CI 0.35, 0.74, p = 0.0036). …”
-
78
-
79
-
80